Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 5:29 pm Purchase | 2025-10-16 | 13D | NovaBay Pharmaceuticals, Inc. NBY | David E. Lazar | 1,502,080 19.990% | 302,032 (+25.17%) | Filing History |
| 2025-10-17 5:10 pm Unchanged | 2025-10-15 | 13D | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 1,020,300 17.520% | 0 (Unchanged) | Filing History |
| 2025-10-15 8:29 pm Purchase | 2025-10-09 | 13D | NovaBay Pharmaceuticals, Inc. NBY | R01 Fund LP | 1,164,117 16.200% | 1,164,117 (New Position) | Filing History |
| 2025-10-15 8:28 pm Purchase | 2025-10-09 | 13D | NovaBay Pharmaceuticals, Inc. NBY | Framework Ventures IV L.P. | 1,164,117 16.200% | 1,164,117 (New Position) | Filing History |
| 2025-09-04 7:21 pm Unchanged | 2025-09-03 | 13D | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 1,020,300 17.520% | 0 (Unchanged) | Filing History |
| 2025-08-26 4:11 pm Purchase | 2025-08-19 | 13D | NovaBay Pharmaceuticals, Inc. NBY | David E. Lazar | 1,200,048 19.990% | 1,200,048 (New Position) | Filing History |
| 2025-06-04 12:46 pm Purchase | 2025-06-03 | 13D | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 1,020,300 17.540% | 48,646 (+5.01%) | Filing History |
| 2025-05-15 09:00 am Purchase | 2025-03-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 971,654 16.710% | 350,969 (+56.55%) | Filing History |
| 2025-02-06 6:30 pm Purchase | 2025-01-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 620,685 12.700% | 242,388 (+64.07%) | Filing History |
| 2025-01-10 6:06 pm Purchase | 2024-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Poplar Point Capital Management LLC | 378,297 7.700% | 378,297 (New Position) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:52 pm Purchase | 2023-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Armistice Capital, LLC | 10,884 4.990% | 5,404 (+98.59%) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Altium Capital Management LLC | 18,132 4.990% | 18,132 (New Position) | Filing History |
| 2024-02-06 11:52 am Purchase | 2023-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Hudson Bay Capital Management LP | 20,534 9.990% | 14,079 (+218.13%) | Filing History |
| 2023-02-14 1:11 pm Purchase | 2022-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Armistice Capital, LLC | 5,481 9.990% | 5,481 (New Position) | Filing History |
| 2023-02-10 3:03 pm Purchase | 2022-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Hudson Bay Capital Management LP | 6,455 9.990% | 6,455 (New Position) | Filing History |
| 2022-02-04 3:13 pm Purchase | 2021-12-31 | 13G | NovaBay Pharmaceuticals, Inc. NBY | Hudson Bay Capital Management LP | 4,058 9.990% | 4,058 (New Position) | Filing History |